Use of benzamidine as a proteolytic inhibitor in the radioimmunoassay of glucagon in plasma.
about
Isolation of dynein heavy chain cDNAs from trout testis which predict an extensive carboxyl-terminal alpha-helical coiled-coil domainGlucagonoma syndrome in a 19-year-old woman.Intra-islet insulin permits glucose to directly suppress pancreatic A cell function.Plasma glucagon and insulin in rat pregnancy. Roles in glucose homeostasis.Somatostatin blockade of acute and chronic stimuli of the endocrine pancreas and the consequences of this blockade on glucose homeostasis.Effects of alternations of plasma free fatty acid levels on pancreatic glucagon secretion in man.Adrenergic modulation of pancreatic glucagon secretion in man.A physiologic role for somatostatin 28 as a regulator of insulin secretionHeterogeneity and compartmental properties of insulin storage and secretion in rat islets.Elimination of the action of glucagon-like peptide 1 causes an impairment of glucose tolerance after nutrient ingestion by healthy baboons.Hyperglucagonemia and alpha-adrenergic receptor in acute hypoxia.The effect of adrenergic blockade on the glucagon responses to starvation and hypoglycemia in man.Differential effects of somatostatin analogues on alpha- and beta-cells of the pancreas.Role of glucagon in mediating metabolic effects of epinephrine.Role of pancreatic somatostatin in determining glucagon response to arginine and morphine.Evidence of a paracrine role for pancreatic somatostatin in vivo.Comparison of glucagon responses to 2-deoxy-D-glucose and hypoglycemia in man.Endogenous hyperglycemia restores insulin release impaired by somatostatin analogue.Reduced triglyceride secretion: a metabolic consequence of chronic exercise.Early activation of cardiac and renal endothelin systems in experimental heart failure.Effects of single large doses of phenytoin on glucose homeostasis--a preliminary report.
P2860
Q33566526-ADB17396-BAD0-44FA-AC44-8D352FF14C3FQ34051859-40F35FE7-7731-4AB6-8455-BC72C018647BQ34197036-CD9E2C0B-8C32-499A-B6F4-78BAE836E719Q34472611-5FD6B58A-255F-46BF-9E2C-BC4ECF0A2FA7Q34476572-81D8FE7E-66F7-41C5-A527-28458A737BFFQ34517171-F5990D31-FEEA-4ECA-8B8B-F1F22F964AB7Q34517832-CDA2716B-6288-4ECF-9C33-CA69160B167CQ35814265-6ABD217B-9184-468C-9190-3C469ECC11CCQ37008325-03146610-F464-4B7D-AF61-29BC909FE83DQ37351161-E02FB3FB-6F65-414B-9E7B-1DC56479881DQ40264172-0CDE60AB-D95E-4420-8E3D-FE230A23895EQ40368822-9AB45EA8-1ACF-4E83-9E72-408DEF264027Q41002028-54063D5E-D5DC-4385-B623-49D08719AC05Q41256831-A501BEB8-3EB8-40BE-AF7B-57C1EAE0043AQ41344408-52BC5FE1-119F-446F-81F5-FEDC7F9EF0F8Q41535276-79035C5C-92AB-4AE3-A4C5-36A78850D094Q41614711-860AF419-2D57-4159-ADD0-1277E102A338Q42446031-9F57D236-171A-4F4A-804D-4AA27F208B76Q44076802-F3FCBD9F-184E-4CBF-9195-FA5AF8D74550Q44653196-6B10B731-A1A5-4A6A-9D99-A43776B24F4CQ51652112-421626EE-3532-4477-99AC-4F67A9962367
P2860
Use of benzamidine as a proteolytic inhibitor in the radioimmunoassay of glucagon in plasma.
description
1972 nî lūn-bûn
@nan
1972年の論文
@ja
1972年学术文章
@wuu
1972年学术文章
@zh
1972年学术文章
@zh-cn
1972年学术文章
@zh-hans
1972年学术文章
@zh-my
1972年学术文章
@zh-sg
1972年學術文章
@yue
1972年學術文章
@zh-hant
name
Use of benzamidine as a proteo ...... noassay of glucagon in plasma.
@en
Use of benzamidine as a proteo ...... noassay of glucagon in plasma.
@nl
type
label
Use of benzamidine as a proteo ...... noassay of glucagon in plasma.
@en
Use of benzamidine as a proteo ...... noassay of glucagon in plasma.
@nl
prefLabel
Use of benzamidine as a proteo ...... noassay of glucagon in plasma.
@en
Use of benzamidine as a proteo ...... noassay of glucagon in plasma.
@nl
P2093
P356
P1476
Use of benzamidine as a proteo ...... noassay of glucagon in plasma.
@en
P2093
P304
P356
10.1210/JCEM-35-3-463
P407
P577
1972-09-01T00:00:00Z